文献速递性腺与生殖内分泌糖尿病肥胖与代谢综合征

多囊卵巢综合征生理通路通过遗传位点聚类揭示

Polycystic Ovary Syndrome Physiologic Pathways Implicated Through Clustering of Genetic Loci.
PubMed 文献 · J Clin Endocrinol Metab · 2024-01-01

研究对60个多囊卵巢综合征(PCOS)相关遗传变异与49个性状进行聚类分析,识别出4个遗传集群,分别与肥胖/胰岛素抵抗、激素/月经周期改变、血液标志物/炎症及代谢改变相关。集群特异性多基因评分与不同临床表型及2型糖尿病等结局相关,提示PCOS遗传背景异质性可能解释其临床异质性与疾病结局。

要点

  • PCOS相关遗传变异可聚类为4个与不同病理生理通路相关的遗传集群。
  • 集群1多基因评分与体重指数升高相关(P=6.6×10-29),集群2与初潮年龄增大相关(P=1.5×10-4)。
  • 集群1多基因评分与2型糖尿病风险升高相关(OR 1.07;P=7.3×10-50),并在MGBB中复制。

核心结论

  • PCOS个体的不同遗传背景可能解释其临床异质性和疾病结局。

研究设计与样本

  • 对60个PCOS相关遗传变异和49个性状使用GWAS汇总统计进行聚类分析。
  • 生成集群特异性PCOS分区多基因评分(pPS),在Mass General Brigham Biobank(MGBB,N=62 252)中检验与临床表型的关联。
  • 使用基于GWAS的pPS(DIAMANTE,N=898 130;CARDIOGRAM/UKBB,N=547 261)和MGBB个体水平pPS评估与临床结局的关联。

主要发现

  • 识别出4个PCOS遗传集群,顶级位点分别为:集群1/肥胖/胰岛素抵抗(FTO);集群2/激素/月经周期改变(FSHB);集群3/血液标志物/炎症(ATXN2/SH2B3);集群4/代谢改变(MAF、SLC38A11)。
  • 集群1 pPS与体重指数升高相关(P=6.6×10-29);集群2 pPS与初潮年龄增大相关(P=1.5×10-4)。
  • 集群3 pPS与多个血液标志物降低相关,包括平均血小板体积(P=3.1×10-5);集群4 pPS与碱性磷酸酶升高相关(P=.007)。
  • 集群1 pPS与2型糖尿病风险升高相关(OR 1.07;P=7.3×10-50),在MGBB全部参与者中复制(OR 1.09,P=2.7×10-7),仅在女性中复制(OR 1.11,P=4.8×10-5)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Polycystic ovary syndrome (PCOS) is a heterogeneous disorder, with disease loci identified from genome-wide association studies (GWAS) having largely unknown relationships to disease pathogenesis. OBJECTIVE: This work aimed to group PCOS GWAS loci into genetic clusters associated with disease pathophysiology. METHODS: Cluster analysis was performed for 60 PCOS-associated genetic variants and 49 traits using GWAS summary statistics. Cluster-specific PCOS partitioned polygenic scores (pPS) were generated and tested for association with clinical phenotypes in the Mass General Brigham Biobank (MGBB, N = 62 252). Associations with clinical outcomes (type 2 diabetes [T2D], coronary artery disease [CAD], and female reproductive traits) were assessed using both GWAS-based pPS (DIAMANTE, N = 898,130, CARDIOGRAM/UKBB, N = 547 261) and individual-level pPS in MGBB. RESULTS: Four PCOS genetic clusters were identified with top loci indicated as following: (i) cluster 1/obesity/insulin resistance (FTO); (ii) cluster 2/hormonal/menstrual cycle changes (FSHB); (iii) cluster 3/blood markers/inflammation (ATXN2/SH2B3); (iv) cluster 4/metabolic changes (MAF, SLC38A11). Cluster pPS were associated with distinct clinical traits: Cluster 1 with increased body mass index (P = 6.6 × 10-29); cluster 2 with increased age of menarche (P = 1.5 × 10-4); cluster 3 with multiple decreased blood markers, including mean platelet volume (P = 3.1 ×10-5); and cluster 4 with increased alkaline phosphatase (P = .007). PCOS genetic clusters GWAS-pPSs were also associated with disease outcomes: cluster 1 pPS with increased T2D (odds ratio [OR] 1.07; P = 7.3 × 10-50), with replication in MGBB all participants (OR 1.09, P = 2.7 × 10-7) and females only (OR 1.11, 4.8 × 10-5). CONCLUSION: Distinct genetic backgrounds in individuals with PCOS may underlie clinical heterogeneity and disease outcomes.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Stamou MI, Smith KT, Kim H, et al. Polycystic Ovary Syndrome Physiologic Pathways Implicated Through Clustering of Genetic Loci. J Clin Endocrinol Metab. 2024. PMID: 37967238. doi:10.1210/clinem/dgad664

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。